Registered Nurse in Channahon, IL Accepting Medicare
3 Registered Nurse nurses found. Showing 1 - 3
 Sarah Pettry-soto, FNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 27240 W Saxony Dr Ste 201, Channahon, IL 60410 Phone: 815-467-1518 Fax: 815-467-7419 |
Sheri Pierce, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 24513 S Serrano Ct, Channahon, IL 60410 Phone: 815-780-4642 |
Beverly Renee Woods, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 26926 W Hemlock Rd, Channahon, IL 60410 Phone: 630-267-5325 Fax: 815-467-0257 |
News Archive
Endosense, Siemens Healthcare enter joint catheter ablation development project
Endosense, a Swiss medical technology company, and Siemens Healthcare, one of the world's largest suppliers to the healthcare industry, have agreed to commence a joint development project intended to integrate the contact-force data provided by Endosense's TactiCath® force-sensing ablation catheter with Siemens' electrophysiology solutions.
Ultraconserved non-coding RNAs may be important in human cancer
Research here shows that an obscure form of RNA, part of the protein-making machinery in all cells, might play an important role in human cancer.
Gates Foundation appoints global health policy head to lead new London office
The Bill & Melinda Gates Foundation announced on Thursday that Joe Cerrell, who currently leads the foundation's global health policy and advocacy group, will head a new Gates Foundation office in London beginning in January 2010, the Wall Street Journal reports.
ASA urges patients to make lifestyle changes before opting for complicated surgeries
At a time of year when people make plans to drop a few pounds, perhaps even consider bariatric surgery, the American Society of Anesthesiologists (ASA) wants to ensure the public has the facts regarding one's weight and the impact it may have on his or her anesthesia experience.
Incyte presents data on INCB28050 Phase IIa trial for rheumatoid arthritis at ACR/ARHP Meeting
Incyte Corporation announced the presentation of final six-month clinical data from the dose ranging, placebo-controlled Phase IIa trial of its orally available janus kinase (JAK) inhibitor INCB28050 in patients with active rheumatoid arthritis (RA).
› Verified 1 days ago